Dewpoint Therapeutics
Chi Zhang is the Group Leader at Dewpoint Therapeutics. He has a Bachelor’s degree in Biotechnology from Peking University in China then got a PhD in Computational Biology from Washington University in St. Louis. Afterwards, he worked at Pfizer and Eisai as a computational biologist before joining Dewpoint. At Dewpoint, Chi Zhang is leading a group of computational biologists to identify and validate biocondensate targets for drug discovery research.
This person is not in any offices
Dewpoint Therapeutics
Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.